福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRTX 福泰制药

休市中 12-27 16:00:00 EST

408.76

-1.89

-0.46%

盘后410.12

+1.36+0.33%

19:56 EST

最高410.98	最低404.49	成交量137.35万
今开405.26	昨收410.65	日振幅1.58%
总市值1,053亿	流通市值1,050亿	总股本2.58亿
成交额5.60亿	换手率0.53%	流通股本2.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":408.76,"timestamp":1735333200000,"preClose":410.65,"halted":0,"volume":1373494,"hourTrading":{"tag":"盘后","latestPrice":410.12,"preClose":408.76,"latestTime":"19:56 EST","volume":72370,"amount":29582603.8747,"timestamp":1735347394243},"delay":0,"floatShares":256789562,"shares":257529290,"eps":-1.862279,"marketStatus":"休市中","change":-1.89,"latestTime":"12-27 16:00:00 EST","open":405.26,"high":410.98,"low":404.49,"amount":560054210.30744,"amplitude":0.015804,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.862279,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1735549200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":410.65,"preHourTrading":{"tag":"盘前","latestPrice":405.77,"preClose":410.65,"latestTime":"09:29 EST","volume":308,"amount":125551.98656,"timestamp":1735309799830},"postHourTrading":{"tag":"盘后","latestPrice":410.12,"preClose":408.76,"latestTime":"19:56 EST","volume":72370,"amount":29582603.8747,"timestamp":1735347394243},"volumeRatio":0.35626319195676204,"impliedVol":0.3085,"impliedVolPercentile":0.6746},"requestUrl":"/m/hq/s/VRTX/wiki","defaultTab":"wiki","newsList":[{"id":"2494854839","title":"Scotiabank上调Vertex目标价至430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494854839","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494854839?lang=zh_cn&edition=full","pubTime":"2024-12-26 15:01","pubTimestamp":1735196481,"startTime":"0","endTime":"0","summary":"格隆汇12月26日｜Scotiabank：将Vertex Pharmaceuticals的目标价从426美元上调至430美元，维持“与行业同步”评级。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122615012695ed716d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122615012695ed716d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2494048123","title":"RBC Capital下调Vertex目标价至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494048123","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494048123?lang=zh_cn&edition=full","pubTime":"2024-12-25 17:42","pubTimestamp":1735119722,"startTime":"0","endTime":"0","summary":"格隆汇12月25日｜RBC Capital：将Vertex Pharmaceuticals的目标价从451美元下调至400美元，维持“持有”评级。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225174206984e9c75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225174206984e9c75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2493087617","title":"美国研究综述-BTCS、Gevo、ServiceNow","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087617","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493087617?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:46","pubTimestamp":1735051586,"startTime":"0","endTime":"0","summary":"美国研究综述-BTCS、Gevo、ServiceNow路透12月24日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 BTCS、Gevo 和 ServiceNow。* BTCS Inc BTCS.O：H.C. Wainwright将目标价从3美元上调至5美元 * Gevo Inc GEVO.O：杰富瑞将目标价从 0.6 美元上调至 1.4 美元 * ServiceNow Inc NOW.N：雷蒙德-詹姆斯给予该公司 \"跑赢大盘 \"的评级 * Vertex Pharmaceuticals Inc VRTX.O：Truist Securities将其目标价从550美元下调至460美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241224:nL4T3NP0PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1917777945.USD","LU2236285917.USD","BK4211","BK4503","LU0061475181.USD","LU0011850046.USD","IE00B19Z9P08.USD","BHLB","LU1430594728.SGD","LU1923622614.USD","UPST","LU2458330243.SGD","LU0943347566.SGD","BK4131","ENTA","LU0289739699.SGD","IE00B4R5TH58.HKD","LU2125909247.SGD","BK4532","LU0109391861.USD","LU2462157665.USD","LU0251131958.USD","BTCS","BRKL","IE0002141913.USD","LU0689472784.USD","IE00B19Z3B42.SGD","LU0058720904.USD","IE00BZ9MQY76.HKD","LU0310800965.SGD","LU0820561909.HKD","LU2125909759.SGD","LU0742534661.SGD","GEVO","FDX","LU1035775433.USD","LU1069344957.HKD","LU0719512351.SGD","IE0009355771.USD","LU0316494557.USD","LU0052756011.USD","LU2362540622.SGD","LU2362541513.USD","BK4581","LU0234570918.USD","LU1093756325.SGD","LU1571399168.USD","NOW","VRTX"],"gpt_icon":1},{"id":"2493089282","title":"Truist下调Vertex目标价至460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493089282","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493089282?lang=zh_cn&edition=full","pubTime":"2024-12-24 21:24","pubTimestamp":1735046660,"startTime":"0","endTime":"0","summary":"Truist：将Vertex Pharmaceuticals的目标价从550美元下调至460美元，维持“买入”评级。(格隆汇)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224212428984d7310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224212428984d7310&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2493718531","title":"福泰制药涨0.69% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2493718531","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493718531?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:33","pubTimestamp":1734986018,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日00时09分，福泰制药股票出现异动，股价急速上涨0.69%。截至发稿，该股报400.01美元/股，成交量49.3333万股，换手率0.19%，振幅2.01%。福泰制药股票所在的生物技术行业中，整体涨幅为0.34%。消息层面，截至00时09分，《巴克莱：维持Vertex Pharmaceuticals评级》资讯为影响福泰制药的重要信息。该信息摘要如下：巴克莱：维持vertex Pharmaceuticals评级，由持股观望调整至持股观望评级,目标价由509.00美元调整至418.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-12-24/doc-ineanqmh9060472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IE0009355771.USD","LU2417539215.USD","LU2237438978.USD","LU0079474960.USD","LU0061475181.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU0256863811.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU2362541273.HKD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","VRTX","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","IE0002141913.USD","BK4533","LU0109394709.USD","IE00B894F039.SGD","LU0417517546.SGD","LU2456880835.USD","BK4588","LU1585245621.USD","LU2362541513.USD","BK4139","IE00B2B36J28.USD","IE0002270589.USD","LU0289739699.SGD","LU1035775433.USD","LU1069344957.HKD","IE00B4R5TH58.HKD","LU2324357040.USD","IE00B19Z9Z06.USD","LU1430594728.SGD","BK4585","LU0889565916.HKD","LU0234570918.USD","LU1093756325.SGD","IE00B19Z3581.USD","BK4567","BK4532","IE00BZ9MQY76.HKD"],"gpt_icon":0},{"id":"2493649877","title":"Truist Securities：维持Vertex Pharmaceuticals(VRTX.US)评级，由买入调整至买入评级, 目标价由550.00美元调整至460.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2493649877","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493649877?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:32","pubTimestamp":1734967971,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Vertex Pharmaceuticals(VRTX.US)评级，由买入调整至买入评级, 目标价由550.00美元调整至460.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/23233246726713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2493873493","title":"福泰制药新一代囊性纤维化疗法获FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2493873493","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493873493?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:21","pubTimestamp":1734945680,"startTime":"0","endTime":"0","summary":"CF是一种罕见的、进行性、缩短寿命的遗传病，累及肺、肝、胰腺、胃肠道、鼻窦、汗腺和生殖道。全球有超过9.2万例CF患者。患者的中位死亡年龄为30多岁，但若得到恰当治疗，其生存率可得到提高。FDA此次批准Vanza三联疗法上市主要是基于3项III期研究的积极结果。结果显示，Vanza三联疗法在6-11岁CF患者与12岁及以上CF患者中的安全性相似。结果显示，在ppFEV1主要终点方面，Vanza三联疗法非劣效于Trikafta。此外，多项关键次要终点达到了优效性标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172653a204577b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172653a204577b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0061475181.USD","IE00B894F039.SGD","LU0234570918.USD","LU2324357040.USD","IE0002270589.USD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","BK4567","LU2236285917.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU2362541513.USD","VRTX","LU0079474960.USD","LU0256863811.USD","BK4533","IE00B2B36J28.USD","LU0289739699.SGD","BK4585","BK4139","LU0109394709.USD","LU0320765992.SGD","LU2362541273.HKD","LU2362540622.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU0058720904.USD","LU1035775433.USD","LU0823416689.USD","LU1069344957.HKD","LU1093756325.SGD","IE0009355771.USD","LU2417539215.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0417517546.SGD","BK4532","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU1093756168.USD","BK4588"],"gpt_icon":0},{"id":"2493781548","title":"美国研究综述-赫希、Paychex、Revvity","url":"https://stock-news.laohu8.com/highlight/detail?id=2493781548","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493781548?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:07","pubTimestamp":1734937640,"startTime":"0","endTime":"0","summary":"美国研究综述-赫希、Paychex、Revvity路透12月23日 - 华尔街证券分析师周一调整了对包括好时、Paychex 和 Revvity 在内的几家美国上市公司的评级和目标价。要闻 * 好时HSY.N：杰富瑞将目标价从155美元下调至150美元 * Paychex Inc PAYX.O：贝尔德将目标价从139美元上调至143美元 * Revvity Inc RVTY.N：杰富瑞将目标价从125美元下调至120美元 * Vertex Pharmaceuticals Inc VRTX.O：丰业银行将目标价从426美元上调至430美元 * Winnebago Industries Inc WGO.N：杰富瑞将目标价从58美元下调至55美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4S3NO0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ9MQY76.HKD","JLL","LEGN","BGS","IIPR","LU0109394709.USD","LU0128526141.USD","LU0320765992.SGD","BK4567","IE00BJT1NW94.SGD","CVGW","HALO","VRTX","BK1576","RVTY","01548","HSY","BK1141","VITL","LEN","LU0417517546.SGD","LU0690374961.EUR","UNIT","AADI","PIPR","BK4099","LU2089984988.USD","HK0000320264.USD","KNF","IE00B19Z9Z06.USD","SYK","REPL","NBIX","LU1035775433.USD","LU0234570918.USD","LW","WGO","IONS","LU0054578231.USD","LU1430594728.SGD","BK4139","BK4079","PAYX","FLO","MGPI","BK4588","SJM","LU0114720955.EUR","IE00BJJMRZ35.SGD","GB00B4QBRK32.GBP"],"gpt_icon":0},{"id":"2493479669","title":"美国 FDA 批准 Vertex 制药公司的囊性纤维化三联疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479669","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493479669?lang=zh_cn&edition=full","pubTime":"2024-12-21 04:51","pubTimestamp":1734727875,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透12月20日 - Vertex制药公司周五表示，美国食品和药物管理局已经批准了该公司治疗一种罕见的渐进性遗传疾病的下一代疗法  ，从而扩大了该公司在囊性纤维化市场的主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU2362541273.HKD","IE00B2B36J28.USD","LU2417539215.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU2362540622.SGD","BK4023","BK4532","BK4139","IE0002270589.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1585245621.USD","LU0256863811.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU1035775433.USD","VRTX","IE00B19Z3581.USD","LU1093756168.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2462157665.USD","IE00B19Z9P08.USD","LU2456880835.USD","BK4533","IE00BZ9MQY76.HKD","LU0079474960.USD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4567","LU0061475181.USD","LU0058720904.USD","LU0289739699.SGD","LU1430594728.SGD","LU1559883803.SGD","LU0823416689.USD","LU1069344957.HKD","LU2237438978.USD","VERX","LU1093756325.SGD","LU0566484027.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2493447276","title":"巴克莱：维持Vertex Pharmaceuticals评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2493447276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493447276?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:38","pubTimestamp":1734719894,"startTime":"0","endTime":"0","summary":"巴克莱：维持vertex Pharmaceuticals(VRTX.US)评级，由持股观望调整至持股观望评级,目标价由509.00美元调整至418.00美元。福泰制药(VRTX.US)公司简介：福泰制药股份有限公司是一家全球性的生物技术公司，致力于发现、开发、制造和商业化用于严重疾病患者的小分子药物。该公司专注于开发和商业化治疗囊性纤维化、感染性疾病(包括流感和细菌感染等病毒感染)、自身免疫性疾病(如类风湿关节炎)、癌症、炎症性肠病和神经系统疾病(包括疼痛和多发性硬化症)的疗法。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221024448a1fe8eb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221024448a1fe8eb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2493476280","title":"福泰制药涨0.90% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2493476280","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493476280?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:50","pubTimestamp":1734717000,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时50分，福泰制药股票出现异动，股价急速上涨0.90%。截至发稿，该股报400.22美元/股，成交量217.33万股，换手率0.84%，振幅3.37%。福泰制药股票所在的生物技术行业中，整体涨幅为0.88%。消息层面，截至01时50分，《福泰制药止痛药物面临“安慰剂效应” 遭Oppenheimer下调评级》资讯为影响福泰制药的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/us/2024-12-21/doc-ineacxhf8735970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0109394709.USD","BK4588","LU1069344957.HKD","LU1430594728.SGD","LU0234570918.USD","LU0417517546.SGD","IE0002270589.USD","LU0823416689.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","LU2462157665.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0061475181.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU2362541513.USD","VRTX","LU2324357040.USD","LU0256863811.USD","BK4139","LU1585245621.USD","LU1093756325.SGD","BK4533","LU2237438978.USD","LU0079474960.USD","IE00B894F039.SGD","LU0889565916.HKD","LU2362540622.SGD","LU0058720904.USD","LU2362541273.HKD","LU0289739699.SGD","BK4567","IE00B19Z9Z06.USD","BK4532","BK4585","LU0320765992.SGD","LU1093756168.USD","LU2236285917.USD","LU2417539215.USD","LU2456880835.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2492462575","title":"美国研究综述-Ares Management、Evercore、Tompkins Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492462575","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492462575?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:06","pubTimestamp":1734678388,"startTime":"0","endTime":"0","summary":"美国研究综述-Ares Management、Evercore、Tompkins Financial路透12月20日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Ares Management、Evercore 和 Tompkins Financial。要闻 * Ares Management Corp ARES.N：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4T3NL0FI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCEL","PGR","PLMR","LU0444973449.USD","NOW","FISI","TMO","ZG","VRTX","MC","AIG","CTAS","CAG","MKL","TROW","RLI","VVV","EVR","AROW","LU0648000940.SGD","LW","KMX","LU2506951958.HKD","LU2420271590.USD","BK4561","FVRR","AA","PSNL","ARES","FDX","TMP","NUS","DRI","CVX","LEN","LSEG.UK","PAYX","TW","PIPR","TEX","USAW.SI","HIG","CHMG","AFG","LAZ","KNSL"],"gpt_icon":1},{"id":"2492628694","title":"福泰制药(VRTX.US)止痛药物面临“安慰剂效应” 遭Oppenheimer下调评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492628694","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492628694?lang=zh_cn&edition=full","pubTime":"2024-12-20 14:53","pubTimestamp":1734677628,"startTime":"0","endTime":"0","summary":"智通财经获悉，Oppenheimer将福泰制药公司的股票评级从“跑赢大盘”下调为“与市场一致”，此前该公司公布了suzetrigine治疗腰骶神经根病的二期研究结果。该公司表示，事后分析引起了对稳健性和在后续试验中证明疗效的潜力的担忧，尽管福泰制药计划进入3期项目，等待FDA的讨论。它引用了suzetrigine治疗腰骶神经根病的益处和风险不确定，以及在2025年1月30日之前对其急性支付的商业潜力的怀疑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VRTX"],"gpt_icon":0},{"id":"2492435451","title":"谷歌版o1模型发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2492435451","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492435451?lang=zh_cn&edition=full","pubTime":"2024-12-20 07:21","pubTimestamp":1734650466,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c2f3f40f5c35dcc9a176cfdd62714a4e","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SGXZ31699556.SGD","LU2461242641.AUD","LU1868837300.USD","LU2592432038.USD","LU1935042215.USD","LU0353189680.USD","LU1267930227.SGD","LU0211327993.USD","LU2361045086.USD","VERX","IE00BKPKM429.USD","IE0009356076.USD","LU0557290698.USD","LU0006306889.USD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2491050154.USD","LU1035773651.USD","LU1585245621.USD","USJW.SI","LU1280957306.USD","LU1935043023.USD","GOOG","BK4581","SG9999002224.SGD","LU0345768153.USD","LU0310799852.SGD","GOOGL","LU0823416689.USD","LU0994945656.USD","LU2463028550.USD","LU0444971666.USD","LU0068578508.USD","LU0310800965.SGD","OTX.SI","IE00B7KXQ091.USD","LU2458330169.SGD","VRTX","LU1935042488.USD","SG9999014898.SGD","SGXZ81514606.USD","LU0079474960.USD","LU2286300806.USD","IE0005OL40V9.USD","LU1951198990.SGD","LU1803068979.SGD","IE0004445239.USD","LU1261432733.SGD","IE00BN29S564.USD","BK4566"],"gpt_icon":0},{"id":"2492107797","title":"BUZZ--美国股票走势-达顿餐厅、Natgas 公司、Affirm 控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492107797","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492107797?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:42","pubTimestamp":1734633724,"startTime":"0","endTime":"0","summary":"美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.59%，报42574.63点；标普500指数.SPX上涨0.50%，报5901.62点；纳斯达克综合指数.IXIC上涨0.49%，报19486.76点。nL4N3NK1B5  ** Tapestry TPR.N：BUZZ--在杰富瑞将评级上调至 \"买入\"、PT上调至街市高位后上涨 nL4N3NK0Y0X ** Peloton Interactive PTON.O:BUZZ - 股价上涨；Telsey Advisory Group上调PT评级 nL4N3NH0X8  ** 埃森哲ACN.N:BUZZ - 上调25财年收入预期后股价上涨 nL4N3NK1AQ  ** Oklo OKLO.N:BUZZ - 在Wedbush将其评级定为 \"跑赢大盘 \"后股价上涨 nL4N3NK10D  ** Okta OKTA.O:BUZZ - 因KeyBanc将其评级上调至 \"增持 \"而上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4S3NK1JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WBD","LW","VRTX","LU0289961442.SGD","ZM","DRI","TPET","MU","TPR","PBM","SHCO","CAG","PTON","AMAT","LYV","SRE","KMX","EWCZ","BK4208","CTAS","ACN","OKTA","VNCE","AFRM","EQT","GEV","CMCSA","MRKR","WGO","USB","LU2362541513.USD","KBR","RTX","PAYX","ALT","NEXT","CNX"],"gpt_icon":1},{"id":"2492170160","title":"BUZZ--美国股票走势-Paychex、RTX、波音公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492170160","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492170160?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:50","pubTimestamp":1734623434,"startTime":"0","endTime":"0","summary":".N美东时间10:30，道琼斯工业平均指数.DJI上涨0.33%，报42465.99点。标普500指数.SPX上涨0.34%，报5892.37点；纳斯达克综合指数.IXIC上涨0.30%，报19451.09点。nL4N3NK10M  ** CarMax KMX.N：BUZZ--该公司公布两年多来首次季度销售额增长后上涨。nL4N3NK141  ** Conagra Brands CAG.N:BUZZ - 在下调年度利润预期后下跌 nL4N3NK0ZT  ** Zoom Communications ZM.O:BUZZ - 因杰富瑞看好人工智能货币化计划而上涨 nL6N3NK0H3  ** Marker Therapeutics MRKR.O:BUZZ - 1600万美元私募后下滑 nL4N3NK15T  ** C3.ai AI.N:BUZZ - 因KeyBanc将其评级下调至 \"减持 \"而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK1F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MU","LW","CAG","LU1571399168.USD","BK4130","IE00BFTCPJ56.SGD","APCX","SHCO","LU2360106780.USD","OKTA","BA","KMX","MRKR","LU0661504455.SGD","LU0950375773.USD","BK4560","PTON","CTAS","ACN","BK4141","TPET","BPTH","LU1228905540.USD","IE00B19Z3B42.SGD","USB","DRI","PAYX","BK4528","KBR","PRFX","ZM","EPAM","SOC","RTX","VRTX","TPR","IE00B3S45H60.SGD","LU0823417737.USD","ALT","WGO"],"gpt_icon":1},{"id":"2492176536","title":"BUZZ--美国股票走势-Oklo、Okta、Zoom","url":"https://stock-news.laohu8.com/highlight/detail?id=2492176536","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492176536?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:14","pubTimestamp":1734617668,"startTime":"0","endTime":"0","summary":"** 意法半导体STM.N：BUZZ - 欧洲芯片股在美光发布不乐观的季度指引后下跌 nL8N3NK0CO 。nL4N3NK0X5  ** Tapestry TPR.N：BUZZ--在杰富瑞将评级上调至 \"买入\"、PT上调至街市高位后上涨 nL4N3NK0Y0X ** Peloton Interactive PTON.O:BUZZ - 股价上涨；Telsey Advisory Group上调PT评级 nL4N3NH0X8  ** 埃森哲ACN.N:BUZZ - 上调25财年收入预期后股价上涨 nL4N3NK0XM  ** Oklo OKLO.N:BUZZ - 在Wedbush将其评级定为 \"跑赢大盘 \"后股价上涨 nL4N3NK10D  ** Okta OKTA.O:BUZZ - 因KeyBanc将其评级上调至 \"增持 \"而上涨。nL4N3NK10M  ** CarMax KMX.N：BUZZZ--该公司两年多来首次实现季度销售额增长，股价上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4S3NK18H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MU","SG9999018857.SGD","LU1093756325.SGD","LW","CAG","LU1571399168.USD","IE00BFTCPJ56.SGD","BK4566","LU0061475181.USD","AI","LU0109394709.USD","KMX","LU2286300806.USD","LU2417539215.USD","OKTA","LU2048586759.USD","LU1035775433.USD","MRKR","LU0157215616.USD","PTON","ACN","BK4599","IE0002141913.USD","LU2456880835.USD","IE00B7SZLL34.SGD","SG9999014898.SGD","BK4516","LU1366333091.USD","LU2250418816.HKD","LU0175139822.USD","LU0289739699.SGD","LU1878469433.USD","LU0511384066.AUD","BK4505","LU0323240290.USD","BK4528","IE00B19Z3581.USD","ZM","OKLO","IE00B19Z9P08.USD","LU0056508442.USD","LU1989772923.USD","BK4532","LU0127658192.USD","TPR","VRTX","BK4585","LU0719512351.SGD","ALT","LU2211815571.USD"],"gpt_icon":1},{"id":"2492517814","title":"Vertex(VERX.US)非成瘾性止痛药遭遇“安慰剂效应” 分析师称其带来挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2492517814","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492517814?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:29","pubTimestamp":1734614944,"startTime":"0","endTime":"0","summary":"智通财经获悉，Vertex Pharmaceuticals的非成瘾性药物在中期试验中帮助患者缓解了腰痛，但效果并不比安慰剂好多少。Vertex周四表示，服用该药的参与者和服用安慰剂的参与者之间没有区别。该公司计划在一项关键的后期研究中控制安慰剂效应。这一结果引发了人们对一种药物的质疑，这种药物是Vertex在其核心囊性纤维化治疗之外实现多元化的关键。如果获得批准，Vertex的药物将成为20多年来第一种新型止痛药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4567","LU0289739699.SGD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1430594728.SGD","BK4139","IE00B894F039.SGD","LU0079474960.USD","LU2362541513.USD","LU2462157665.USD","LU2456880835.USD","IE00B2B36J28.USD","LU2362541273.HKD","LU0566484027.USD","IE00B19Z9P08.USD","BK4533","LU1585245621.USD","LU1035775433.USD","LU2236285917.USD","VRTX","LU0417517546.SGD","LU2417539215.USD","LU1069344957.HKD","IE00B19Z3B42.SGD","IE0002270589.USD","LU2362540622.SGD","LU1093756325.SGD","BK4532","VERX","IE00B4R5TH58.HKD","LU0256863811.USD","LU2237438978.USD","IE00B19Z3581.USD","IE00BZ9MQY76.HKD","LU0234570918.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","BK4023","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4588","LU1559883803.SGD","LU0889565916.HKD","LU1093756168.USD","LU0320765992.SGD","LU0061475181.USD","IE0009355771.USD","LU2324357040.USD","LU0058720904.USD","BK4585"],"gpt_icon":0},{"id":"2492129052","title":"BUZZ--美国股票走势-Tapestry、Peloton、埃森哲","url":"https://stock-news.laohu8.com/highlight/detail?id=2492129052","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492129052?lang=zh_cn&edition=full","pubTime":"2024-12-19 20:04","pubTimestamp":1734609849,"startTime":"0","endTime":"0","summary":"** 意法半导体STM.N：BUZZ - 欧洲芯片股在美光发布不乐观的季度指引后下跌 nL8N3NK0CO 。nL4N3NK0X5  ** Tapestry TPR.N：BUZZ--在杰富瑞将评级上调至 \"买入\"、PT上调至街市高位后上涨 nL4N3NK0Y0X ** Peloton Interactive PTON.O:BUZZ - 股价上涨；Telsey Advisory Group上调PT评级 nL4N3NH0X8  ** 埃森哲ACN.N:BUZZ - 上调25财年收入预期后股价上涨 nL4N3NK0XM (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4S3NK105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU1032466523.USD","IE00B2B36J28.USD","BK4585","LU2362541273.HKD","IE00B7SZLL34.SGD","LU0127658192.USD","LU2211815571.USD","LU0642271901.SGD","LU2048586759.USD","LU0545039389.USD","LU1035775433.USD","LU1228905540.USD","LU1228905037.USD","LU1267930227.SGD","LU1989772923.USD","IE00B894F039.SGD","LU0417517546.SGD","SG9999017495.SGD","LU0320765489.SGD","LU0056508442.USD","MU","LU2247934214.USD","LW","LU0289739699.SGD","TPR","LU0208291251.USD","LU0661504455.SGD","BK4575","SG9999004303.SGD","LU2250418816.HKD","IE00BFSS8Q28.SGD","IE0009355771.USD","LU2362540622.SGD","VRTX","IE00B19Z3B42.SGD","IE0002270589.USD","LU0081259029.USD","ACN","LU2360106780.USD","PTON","LU0082616367.USD","BK4561","GB00BDT5M118.USD","LU0323240290.USD","BK4202","LU1506573853.SGD","IE0002141913.USD","IE00B19Z9Z06.USD","IE00BJJMRY28.SGD"],"gpt_icon":1},{"id":"2492126589","title":"BUZZ-试验性药物和安慰剂的镇痛效果相似，Vertex公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2492126589","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492126589?lang=zh_cn&edition=full","pubTime":"2024-12-19 19:39","pubTimestamp":1734608350,"startTime":"0","endTime":"0","summary":"12月19日 -  ** Vertex制药公司VRTX.O股价盘前下跌13%至389美元 ** VRTX表示，其实验性非阿片类药物suzetrigine在一项中期试验中达到了 。** 然而，VRTX 公司称，在腰骶部神经根病(LSR 患者中，该药的止痛效果与安慰剂相似。** 试验的主要目的是通过评分表测量疼痛强度的变化  ** 截至上一交易日收盘，该公司股价已累计上涨约 10(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK0YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU2236285917.USD","IE00BJT1NW94.SGD","IE00B19Z9Z06.USD","LU0079474960.USD","LU2462157665.USD","LU0289739699.SGD","IE00B894F039.SGD","BK4532","LU0058720904.USD","LU0889565916.HKD","LU2362541513.USD","LU2362540622.SGD","LU0234570918.USD","LU1035775433.USD","LU1430594728.SGD","IE0002270589.USD","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","LU0256863811.USD","LU0417517546.SGD","LU1093756325.SGD","BK4585","VRTX","BK4533","LU2362541273.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0109394709.USD","LU2456880835.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1093756168.USD","IE00B2B36J28.USD","LU2417539215.USD","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","BK4139","LU1069344957.HKD","LU0061475181.USD","LU0320765992.SGD","BK4588","LU2237438978.USD","LU2324357040.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":0.0289},{"period":"1month","weight":-0.1201},{"period":"3month","weight":-0.1169},{"period":"6month","weight":-0.1279},{"period":"1year","weight":-0.0012},{"period":"ytd","weight":0.0046}],"compareEarnings":[{"period":"1week","weight":0.0065},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0412},{"period":"6month","weight":0.0933},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.2518}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品：KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.030934},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.001228},{"month":3,"riseRate":0.424242,"avgChangeRate":-0.020541},{"month":4,"riseRate":0.606061,"avgChangeRate":0.017109},{"month":5,"riseRate":0.575758,"avgChangeRate":0.084187},{"month":6,"riseRate":0.545455,"avgChangeRate":0.029065},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.005556},{"month":8,"riseRate":0.647059,"avgChangeRate":0.051926},{"month":9,"riseRate":0.470588,"avgChangeRate":0.031033},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.001666},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.021411},{"month":12,"riseRate":0.647059,"avgChangeRate":0.072735}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}